Jpmorgan Chase & CO Axonics, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Axonics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 657,206 shares of AXNX stock, worth $46.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

657,206

Previous 237,599 176.6%

Holding current value

$46.6 Million

Previous $16 Million 186.65%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$67.3 - $69.67 $28.2 Million - $29.2 Million	419,607 Added 176.6%	657,206 $45.8 Million
Q2 2024 Aug 12, 2024	BUY	$66.47 - $69.65 $10.4 Million - $10.9 Million	157,143 Added 195.32%	237,599 $16 Million
Q1 2024 May 10, 2024	SELL	$56.67 - $69.36 $3.7 Million - $4.53 Million	-65,340 Reduced 44.82%	80,456 $5.55 Million
Q4 2023 Feb 12, 2024	BUY	$49.38 - $63.75 $222,259 - $286,938	4,501 Added 3.19%	145,796 $9.07 Million
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $2.45 Million - $3.15 Million	-50,414 Reduced 26.3%	141,295 $7.93 Million
Q2 2023 Aug 11, 2023	SELL	$47.99 - $60.21 $11 Million - $13.8 Million	-228,518 Reduced 54.38%	191,709 $9.68 Million
Q1 2023 May 18, 2023	BUY	$52.6 - $67.34 $3.25 Million - $4.16 Million	61,810 Added 17.25%	420,227 $22.9 Million
Q1 2023 May 11, 2023	SELL	$52.6 - $67.34 $1.3 Million - $1.67 Million	-24,736 Reduced 6.46%	358,417 $19.6 Million
Q4 2022 Feb 13, 2023	SELL	$59.56 - $76.6 $1.28 Million - $1.65 Million	-21,541 Reduced 5.32%	383,153 $24 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $20.9 Million - $28.2 Million	361,119 Added 828.73%	404,694 $28.5 Million
Q2 2022 Aug 11, 2022	SELL	$39.5 - $64.42 $2.19 Million - $3.57 Million	-55,357 Reduced 55.95%	43,575 $2.47 Million
Q1 2022 May 11, 2022	BUY	$43.74 - $62.76 $212,882 - $305,452	4,867 Added 5.17%	98,932 $6.19 Million
Q4 2021 Feb 10, 2022	BUY	$50.01 - $73.35 $3.3 Million - $4.84 Million	65,924 Added 234.26%	94,065 $5.27 Million
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $1.67 Million - $2.21 Million	28,141 New	28,141 $1.83 Million

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Axonics, Inc. Transaction History